Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
545 studies found for:    Open Studies | "Infant, Newborn, Diseases"
Show Display Options
Rank Status Study
21 Recruiting Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial
Condition: Bronchopulmonary Dysplasia
Interventions: Biological: Pneumostem®;   Biological: normal saline
22 Recruiting Extravascular Lung Water and Pulmonary Vascular Permeability After Minimally Invasive Cardiac Surgery
Condition: Acute Respiratory Distress Syndrome
Intervention:
23 Recruiting Time-motion-mode Ultrasound Diaphragm Measures in Patients With Acute Respiratory Distress in Emergency Department
Condition: Respiratory Distress Syndrome, Adult
Intervention: Device: Vivid S6 GE Ultrasound
24 Recruiting Intermittent Versus Continuous Infusion Meropenem in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention:
25 Not yet recruiting Electrical Activity of Diaphragm as a Means to Predict Extubation Success in Preterm Infants
Condition: Respiratory Distress Syndrome
Intervention:
26 Recruiting Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off Cycles
Condition: Cystic Fibrosis
Intervention: Drug: Tobramycin Inhalation Powder
27 Unknown  Prevention of CF Exacerbation in Childhood: PREVEC Study
Conditions: Cystic Fibrosis;   Children;   Exhaled Breath Condensate;   Non-invasive Inflammatory Markers;   Volatile Organic Compounds
Interventions: Other: Diagnostic intervention without standard therapy;   Other: Diagnostic intervention with standard therapy
28 Not yet recruiting Lentiviral Gene Therapy for Adenosine Deaminase (ADA) Deficiency
Conditions: Adenosine Deaminase Deficiency;   Severe Combined Immunodeficiencies (SCID)
Intervention: Genetic: EF1αS-ADA lentiviral vector transduced patient Cd34+ cells
29 Recruiting Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: AquADEKs-2;   Dietary Supplement: control multivitamin
30 Recruiting Comparison of Two Methods to Estimate the Lung Recruitment
Conditions: Acute Respiratory Distress Syndrome;   Acute Lung Injury
Intervention: Procedure: CT scan and Pressure volume curve
31 Unknown  Two Strategies of RDS Treatment in Newborns With Birth Weight > 1500 Grams
Condition: Respiratory Distress Syndrome
Interventions: Drug: Surfactant;   Device: Nasal CPAP
32 Recruiting Vitamin D Supplementation for Extremely Preterm Infants
Conditions: Vitamin D Deficiency;   Preterm Infants;   Bronchopulmonary Dysplasia
Interventions: Dietary Supplement: Cholecalciferol;   Dietary Supplement: Placebo
33 Unknown  Transpulmonary Gradient After Cardiac Surgery Under Cardiopulmonary Bypass
Condition: Acute Respiratory Distress Syndrome After Cardiac Surgery Under Cardiopulmonary Bypass
Intervention:
34 Unknown  Dietary Lutein and the Retinopathy of Prematurity
Condition: Lactation
Intervention: Dietary Supplement: Lutein supplement
35 Not yet recruiting Aerosolized Surfactant in Neonatal RDS
Condition: Respiratory Distress Syndrome, Newborn
Intervention: Drug: Surfactant
36 Unknown  Standardized Application of High Frequency Oscillatory Ventilation in the Acute Respiratory Distress Syndrome (ARDS)
Condition: Acute Respiratory Distress Syndrome
Intervention:
37 Recruiting Nasal Intermittent Positive-Pressure Ventilation for Twin Infants With Respiratory Distress Syndrome
Condition: Neonatal Respiratory Distress Syndrome
Interventions: Device: nIPPV;   Device: nCPAP
38 Recruiting Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF)
Condition: Cystic Fibrosis
Interventions: Drug: Ataluren (PTC124®);   Drug: Placebo
39 Recruiting Large Observational Study to UNderstand the Global Impact of Severe Acute Respiratory FailurE
Conditions: Acute Severe Respiratory Failure;   Acute Respiratory Distress Syndrome
Intervention:
40 Recruiting Randomized Trial of Maternal Progesterone Therapy
Conditions: Congenital Heart Disease;   Periventricular Leucomalacia;   Brain Development;   Cardiac Surgery;   Neurodevelopmental Disability;   Fetal Neuroprotection
Interventions: Drug: Progesterone;   Drug: Vaginal lubricant

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years